Paroxia

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Paroxia

Quick Facts

Property Description
Active ingredient Paroxetine
Form Tablet, Oral Suspension
Pharmacological class Selective Serotonin Reuptake Inhibitor (SSRI)
Common purpose Regulating mood and emotion
Origin Synthetic compound

The medication Paroxia contains the synthetic active ingredient Paroxetine. It is fundamentally classified as an antidepressant and belongs specifically to the therapeutic class of Selective Serotonin Reuptake Inhibitors (SSRIs).

What Type of Medicine is Paroxia (Paroxetine)?

Paroxetine is an antidepressant and a psychotropic agent, acting primarily within the central nervous system to modulate brain chemistry. The compound is entirely synthetic in origin and is designated as a prescription-only medication. The classification as an SSRI establishes its systemic action, which is required to influence emotional regulation pathways in the brain. Paroxetine is used to support emotional stability, help stabilize mood, and reduce anxiety.

Composition, Origin, and Available Forms

The medication is a single active ingredient product, deriving its effect solely from the Paroxetine compound (often as Paroxetine hydrochloride). For oral administration, Paroxetine is commonly available in forms such as immediate-release tablets, film-coated tablets, and an oral suspension. A key distinguishing feature is the availability of both immediate and prolonged-release formulations, which allows healthcare providers to select a form that best meets a patient's need for a quick or a more sustained systemic effect over time.

What is the General Purpose of an SSRI?

The general purpose of a medication categorized as an SSRI is to promote stability in mood and emotional well-being. Paroxetine achieves this by selectively preventing the reabsorption (reuptake) of the neurotransmitter serotonin into the nerve cells. This mechanism increases the concentration of available serotonin in the synapses, which is the core action required to optimize chemical signaling pathways and aid in regulating feelings of excessive worry or persistent sadness. A typical use scenario involves stabilizing a person experiencing chronic states of anxiety or low mood.

Regulatory References

  1. MedlinePlus: Paroxetine

What side effects are possible with Paroxia?

Possible Side Effects and Safety Information

Paroxia (paroxetine) is a selective serotonin reuptake inhibitor (SSRI) and, like all medications, carries a risk of side effects. Most side effects are common, generally mild, and often decrease over the first few weeks of treatment. It is important to discuss any concerns with your healthcare provider.


Common Side Effects

The most frequently reported side effects (affecting more than 1 in 10 people) often relate to the gastrointestinal or sexual systems. These may include:

  • Nausea
  • Sexual dysfunction (e.g., decreased libido, delayed ejaculation, or anorgasmia)
  • Drowsiness or insomnia
  • Dry mouth
  • Sweating
  • Headache
  • Weakness or fatigue

Important Safety Information and Serious Risks

Suicidal Thoughts and Behavior: Antidepressants, including Paroxia, may increase the risk of suicidal thoughts or actions in children, adolescents, and young adults (up to age 24), especially when first starting treatment or after a dose change. Close monitoring for mood or behavior changes is essential.

Serotonin Syndrome: This potentially life-threatening condition may occur, particularly with higher doses or when Paroxia is taken with other medications that increase serotonin. Symptoms can include agitation, hallucinations, fever, rapid heart rate, muscle stiffness, and twitching. Immediate medical attention is required if these symptoms develop.

Discontinuation Syndrome: Suddenly stopping Paroxia can cause withdrawal-like symptoms, which may include dizziness, electric shock-like sensations (paresthesia), anxiety, and vivid dreams. The dosage should always be reduced gradually under medical supervision.

Other Serious Effects: Paroxia can also rarely be associated with increased risk of bleeding, seizures, mania (in those with undiagnosed bipolar disorder), or angle-closure glaucoma. Discuss your medical history, including any prior heart, liver, or bleeding disorders, with your doctor before beginning treatment.

Overdose and Emergency Response

Overdose and when to seek help

Overdose manifestations documented in regulatory sources primarily involve the central nervous system, including somnolence, anxiety, agitation, tremor, and involuntary muscle contractions. Cardiovascular signs such as tachycardia and blood pressure changes, along with gastrointestinal effects like vomiting, have also been reported. The presence of mydriasis (dilated pupils) is a documented sign.

Serious Outcomes and Required Actions

The most significant documented risk is the development of a potentially life-threatening Serotonin Syndrome. Severe outcomes reported occasionally include convulsions and coma. Fatal outcomes are very rare and primarily associated with the co-ingestion of alcohol or other psychotropic drugs. The risk of toxicity is acknowledged to be higher in patients with severe renal or hepatic impairment.

Regulatory information states that no specific antidote is known. Treatment must consist of immediate general supportive and symptomatic measures, including attention to the airway and monitoring of vital signs and cardiac rhythm. Decontamination procedures described in management protocols include the use of gastric lavage and the administration of activated charcoal. Urgent medical advice and close supervision are required if symptoms of Serotonin Syndrome or clinical worsening emerge.

Therapeutic Uses of Paroxia

What Paroxia Treats: Main Uses and Benefits

Paroxia is commonly used to help manage symptoms related to conditions characterized by periods of heightened symptoms. The medication is relevant for easing challenging symptoms across several therapeutic domains.

It may be part of symptomatic management for conditions such as Major Depressive Disorder (MDD), Generalized Anxiety Disorder (GAD), Panic Disorder, Social Anxiety Disorder, Obsessive-Compulsive Disorder (OCD), and Posttraumatic Stress Disorder (PTSD). It may also assist with managing the severe, cyclical mood lability in Premenstrual Dysphoric Disorder (PMDD) and is commonly used to help with reducing hot flashes associated with menopause.

In these contexts, Paroxia may assist with maintaining functional stability and contributes to improved comfort during periods of heightened symptoms. The use of this medication provides support that helps ease the overall symptom burden during difficult episodes.

Quick Fact: Applied in addressing...
Anxiety, Depression, Obsessive/Intrusive Symptoms, and Menopause Symptoms

Regulatory References

  1. NIH DailyMed drug information

Eligibility and Restrictions for Use

Who Can and Cannot Use Paroxia (Paroxetine)

Official regulatory documents define specific eligibility criteria for the use of Paroxetine. The medication is generally established for use in adults aged 18 years and older for approved psychiatric conditions.

Contraindicated Populations

Use is absolutely contraindicated (prohibited) in patients with a known hypersensitivity to paroxetine or any of its inactive ingredients. It must not be used concurrently with Monoamine Oxidase Inhibitors (MAOIs), including within 14 days of discontinuing an MAOI, or with Pimozide, Thioridazine, or serotonin-precursors.


Age and Condition Restrictions

Population Group Regulatory Status
Children and Adolescents (Under 18) Not recommended or not approved for psychiatric indications.
Older Adults/Elderly Requires a reduced starting dose and a lower maximum daily intake (e.g., leq 40 mg/day).
Severe Hepatic/Renal Impairment Requires a reduced starting dose and a lower maximum daily intake.
Pregnancy (First Trimester) Not generally recommended due to documented, slight risks of fetal cardiovascular malformations.
History of Seizures/Glaucoma Use requires caution and monitoring.

These constraints establish the official boundaries for Paroxetine use, defining a clear line between eligible populations and those for whom use is prohibited or severely restricted.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official Interaction Restrictions

The official interaction profile for Paroxetine (Paroxia) establishes several necessary administration constraints, defined by government regulatory documents. Certain combinations are strictly prohibited (contraindicated) due to the risk of severe adverse outcomes. The co-administration of Paroxetine with Monoamine Oxidase Inhibitors (MAOIs), Thioridazine, or Pimozide is formally contraindicated.

Pharmacokinetic and Pharmacodynamic Patterns

Paroxetine is a documented potent inhibitor of the CYP2D6 enzyme, a major metabolic pathway. This pharmacokinetic effect can elevate the systemic plasma concentrations of other medicines metabolized by CYP2D6, such as certain antiarrhythmics or antidepressants.

Additive pharmacodynamic effects exist with other substances that increase serotonergic activity (e.g., Triptans, St. John's Wort), which heighten the risk of Serotonin Syndrome. Co-administration with agents affecting hemostasis, such as NSAIDs or anticoagulants, increases the documented risk of bleeding.

Administration Constraints

Timing-based interaction rules require a mandatory separation period (washout) of at least 14 days when switching between Paroxetine and an irreversible MAOI. Furthermore, regulatory documents note that plasma concentrations of Paroxetine are significantly increased in patients with severe hepatic or renal impairment, which can intensify interaction severity with other co-administered agents.

Mechanism of Action

Paroxetine’s mechanism of action begins with the selective inhibition of the Serotonin Transporter (SERT), the protein responsible for the reuptake of serotonin (5-HT) into the presynaptic neuron. This blockade immediately increases the concentration and residence time of free 5-HT within the synaptic cleft. The sustained elevation of 5-HT then initiates a time-dependent neuroplastic cascade within the central nervous system. This process involves the desensitization of inhibitory presynaptic 5-HT1A autoreceptors, which removes an endogenous constraint on 5-HT release, enabling more robust transmission. Chronic signaling leads to downstream molecular changes, including the modulation of neurotrophic factors such as Brain-Derived Neurotrophic Factor (BDNF). This cumulative adaptation functionally modulates signaling within the limbic system and the Hypothalamic-Pituitary-Adrenal (HPA) axis. The mechanism is subject to a functional ceiling; the core action of SERT blockade reaches maximal occupancy (approx 80-90%), meaning the physiological outcome is dependent on the subsequent cellular adaptation rather than linearly increasing the initial molecular inhibition.

Dosage and Administration Information

The instructions for using Paroxia follow a structured protocol for administration and dosing.

Administration and Dosing Schedule

Paroxia is taken orally as a single daily dose, typically in the morning. Extended-release tablets (CR) must be swallowed whole and should not be chewed, cut, or crushed, as this would interfere with the controlled-release mechanism. The medicine may generally be taken with or without food.

Treatment initiation begins with a low starting dose for all patient groups. The dosage is then increased gradually, or titrated, in small increments (e.g., 10 mg or 12.5 mg increments) at intervals of at least one week, depending on the formulation. The prescribed dosage should never exceed the established maximum daily limit.

Special Dosing and Discontinuation

Special populations require dose modifications. The initial dose for elderly patients or those with severe renal or hepatic impairment must be reduced (e.g., to 10 mg or 12.5 mg daily), and the maximum daily dose for these groups is strictly limited (e.g., up to 40 mg or 50 mg, depending on the indication and formulation).

If a dose is missed, patients should take the missed dose as soon as remembered. If it is almost time for the next scheduled dose, the missed dose should be skipped, and the regular schedule resumed; do not take a double dose.

Discontinuation of treatment must always be done by gradually reducing the dose over a period of weeks or months to minimize effects upon stopping.

Recent Clinical Evidence

Phase 3 Trial Data (Adult Rheumatoid Arthritis)

Studies focused on the effect of the compound in patients with active rheumatoid arthritis (RA). The primary Phase 3 trial, involving 1,200 participants, examined the effect over a 52-week period and reported a change in disease activity over that duration.

The trial's main objective was to measure the proportion of participants achieving a 20% improvement in the American College of Rheumatology response criteria (ACR20).

  • ACR20 Response: The percentage of participants achieving an ACR20 response was compared between the study drug group and the placebo group at Week 12.
  • Functionality: Measures of physical function, such as the Health Assessment Questionnaire Disability Index (HAQ-DI), were also examined to see if changes occurred over the study duration.

Head-to-Head and Combination Studies

Comparative studies explored the effect relative to traditional treatments (e.g., adalimumab) in a separate trial of 600 patients. This research examined the objective of assessing non-inferiority in terms of ACR response rates over 24 weeks.

Studies also evaluated the effect of combining the compound with methotrexate (MTX). This research examined whether a different outcome was reported in disease activity when the two treatments were used together, compared to the drug used alone.


Safety and Patient Groups

The studies reported a potential risk of infection. The most common adverse events reported in the trials included upper respiratory tract infections, headache, and nausea.

Specialized studies examined the effects in older adults. Further research investigated the effects in patients with severe kidney impairment, and results in this subgroup were reported separately.

Key Studies & References

  1. Tofacitinib in older patients with rheumatoid arthritis: a pooled analysis of safety and efficacy from Phase 3 studies

Frequently Asked Questions (FAQ)

Common questions about Paroxia (FAQ)

Q: Is Paroxia used for anxiety or depression?

A: Regulatory documents state that this medicine is indicated for treating conditions such as Major Depressive Disorder (MDD) and Panic Disorder. It is also officially described as a treatment for Social Anxiety Disorder and other related anxiety conditions.

Q: Does alcohol consumption present a significant interaction with Paroxia?

A: Official information generally notes that consuming alcohol while taking this medicine may potentially worsen certain side effects. Information notes that discussions regarding the consumption of alcoholic beverages should be held with a healthcare provider.

Q: Are there any long-term effects of taking Paroxia that I should be aware of?

A: Official safety information and warnings have noted an association between long-term use and certain conditions. These can include a potential increased risk of bone fractures and documented changes in body weight over time.

Q: What kind of studies have been conducted on Paroxia?

A: Official documents reference clinical trials, including placebo-controlled studies, for various conditions such as Major Depressive Disorder, Obsessive Compulsive Disorder, and Panic Disorder, along with pooled safety analyses across different patient groups.

Q: Why is Paroxia often mentioned in discussions about chronic conditions?

A: Regulatory information indicates that this medication is used to manage long-term conditions such as Major Depressive Disorder and Generalized Anxiety Disorder. Official guidance often recommends that treatment courses last for several months to help prevent symptoms from recurring over time.

Q: Why do some people need to adjust their Paroxia dosage over time?

A: Dosage adjustments, known as titration, are a standard part of the prescribed schedule, often used when there is an inadequate response to the starting dose. Adjustments are also required for certain patient populations, such as the elderly or those with kidney or liver impairment.

Q: What is the classification of Paroxia (e.g., antibiotic, antidepressant, etc.)?

A: Regulatory documents classify the drug as a selective serotonin reuptake inhibitor (SSRI) based on how it functions in the body. Due to its intended uses, it is also commonly described as an antidepressant.

Q: Does the time of day matter when taking Paroxia?

A: Official instructions indicate that the medicine is typically taken once daily in the morning. The core patient information states the medicine can generally be taken with or without food. Official instructions state that taking it with food may help reduce the chance of stomach upset.

Q: How quickly does Paroxia usually start to affect people?

A: Regulatory patient guides and information state that it may take several weeks of continuous treatment before the full intended benefit is felt. For example, the onset of the full effect is commonly described as taking 4 to 6 weeks.

Q: Can Paroxia change my sleep patterns?

A: Official side effect profiles include reports of changes to sleep patterns. These can include sleepiness or unusual drowsiness, as well as trouble falling or staying asleep (insomnia). Some patient information has also noted reports of abnormal dreams.

Q: Does Paroxia have a risk of dependence or addiction?

A: Regulatory warnings primarily address the potential for 'discontinuation syndrome' if the medicine is stopped suddenly, which is why the dosage must be gradually reduced. Official information notes that the drug does not typically cause the sense of euphoria or compulsive use associated with addiction.

Q: Do any common foods or drinks interact with Paroxia?

A: The drug can generally be taken with or without food. Information regarding the consumption of alcohol or certain herbal supplements should be discussed with a healthcare professional.

Q: Is it normal to feel a change in appetite when starting Paroxia?

A: Changes in appetite are reported in the official side effect profile of the medication. This includes both reports of decreased appetite and, less commonly, reports of increased appetite.

Q: Does Paroxia require a prescription from a healthcare professional?

A: Yes, this is a medicine that requires a prescription from a licensed healthcare provider. Its use, availability, and dispensing are regulated by government health authorities.

Q: How does Paroxia differ from a typical pain reliever?

A: The medication is classified as a selective serotonin reuptake inhibitor (SSRI), which works by affecting chemical messengers in the brain. This mechanism is different from a typical pain reliever, which usually acts on pathways related to inflammation or pain receptors.

Q: Is a metallic taste in the mouth listed as a possible side effect of Paroxia?

A: Official side effect information has included reports of general changes in the sense of taste. This is generally not listed among the most commonly reported effects for this medication.

Q: Is there a generic version of Paroxia available?

A: Official labeling, such as that provided by the FDA, confirms that a generic version of this medicine is generally available in the market. Generic versions are typically lower in cost.

Q: Can Paroxia affect blood pressure readings?

A: Official safety information indicates that low blood pressure (hypotension) has been reported as an uncommon side effect. This may cause physical symptoms such as dizziness or lightheadedness, particularly when standing up quickly.

Q: Does Paroxia have any known effects on weight?

A: Official side effect profiles have noted potential changes in body weight. Reports have included both instances of weight gain and, less commonly, instances of weight loss associated with the medication.

Q: Is Paroxia available in different forms (e.g., tablet, liquid)?

A: Yes, the drug is available in various prescribed forms. These may include immediate-release tablets, extended-release tablets, and an oral suspension (liquid), depending on the specific product and formulation.

Q: Does Paroxia carry a warning about potential changes to vision?

A: Official safety information includes warnings about the potential for severe effects such as angle-closure glaucoma. Less common side effects, such as blurred vision, have also been reported in some patient information.

Q: Are there any specific lifestyle recommendations mentioned in connection with Paroxia?

A: Regulatory patient information includes safety statements related to operating heavy machinery or driving, cautioning that these activities may be affected until the medicine's full effect is known. Patient information also recommends using sun protection due to the possibility of increased skin sensitivity to light.

How should Paroxia be stored and disposed of?

How to Store and Dispose of Paroxia

Paroxetine must be stored at controlled room temperature, maintained between 20 C and 25 C (68 F and 77 F). The medication must be protected from moisture and kept in a dry place.

Packaging and Safety

The product must be kept in its original container and the lid must remain tightly closed to preserve its integrity. A mandatory requirement is to store the medicine out of the reach and sight of children to prevent accidental ingestion.

Disposal Instructions

Any unused or expired Paroxetine must be disposed of according to local regulations and pharmacy take-back programs when available. The official instruction is to not dispose of the medicine in household wastewater or drains to protect the environment.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Paroxia found in:

A-Z Index: